Services

Products Services

Safety beyond the visible: Merck Millipore BioMonitoring

BioMonitoring is about innovative testing solutions, regulatory expertise, comprehensive service, and trust more

Services Services

First Global Market Expansion Services report by Roland Berger and DKSH

MES is the new and intelligent outsourcing concept that helps businesses gain access to customers in new markets, and supports them with marketing, more

DKSH is a leading specialty chemicals distributor and global provider of Market Expansion Services

With DKSH Performance Materials, you get value beyond products and services. As your trusted partner, we deliver the insights, capabilities, results more

Think Asia. Think DKSH. Your one-stop partner for chemical distribution throughout Asia

We are your reliable outsourcing partner with Swiss roots and 150 years of experience in Asian markets more

News Services

• Solvias opens new Corporate Location
  

  Just in time for the New Year, the company relocated from Basel to Kaiseraugst. The new laboratories offer more space to provide the pharmaceutical and biopharmaceutical industry with the spectrum of services that includes analysis of large and small molecules, solid-state development, and proce more

• Novartis Pharmaceuticals Corporation restructuring US field force

  Novartis Pharmaceuticals Corporation (NPC) announced that it is restructuring its General Medicines field force in the US to reflect changes in the product portfolio and align resources with strategic growth priorities. The company will reduce its General Medicines field force by approximately 1,40 more

• Chris Beaver joins Pharmanet as Director, Immunochemistry Services

  PharmaNet Development Group, Inc. announced that Chris Beaver, PhD has joined the Company as Director, Immunochemistry Services. Dr. Beaver is responsible for leading the immunochemistry team within the Company’s bioanalytical laboratories and expanding its large molecule services, including assay more

White papers Services

• Outsourcing to India and China: Cultural diffculties with the perception of costs
  

  Aparna Singh (AS), Program Manager for the Chemicals Materials and Foods team at Frost & Sullivan India, recently caught up with Mr. Steve Fishwick (SF), Projects Group Director, AstraZeneca at the Frost & Sullivan's Global Life Sciences Summit 2006 at Goa, India. He was one of the key speakers at this premium summit. more

• Expression Analysis of ABC Transporters in Lung Cancer Cell Lines Using a RealTime ready qPCR Focus Panel
  

  The novel small molecule inhibitors are often substrates of ABC transporters which influence the pharmacokinetic parameters of the drug candidates and cause drug resistance of tumor cells. Therefore expression profiling of ABC transporter genes in cell lines used for drug screening is highly important for anti-cancer drug discovery projects. Our purpose was to create a basic expression profile of ABC transporters in our mainly used lung cancer cell lines using the RealTime ready ABC Transporter Panel.The RealTime ready ABC-Transporter Panel comprises the 42 most important human ABC transporters in duplicate. The panel includes five controls for RNA quality and seven reference gene assays. The assays are supplied in a LightCycler® Instrument 480 Multiwell Plate 96 and contain target specific primers and a FAM-labeled Universal ProbLibrary hydrolysis probe that contains LNA more

• Altered Expression of Broad Range of Protease Genes in SH-SY5Y Neuroblastoma Cells after Bortezomib Exposure
  

  Neuroblastoma cell lines can be models for the responsiveness of neuroblastomas to chemotherapy-induced cell death as well as for the sensitivity of untransformed neuro-nal cells to toxic side-effects of chemotherapy. Both phenom-ena are relevant to neuroblastoma cells exposed to bortezomib, a proteasome inhibitor in clinical use. It has been shown previously that neuroblastoma cell lines are prone to undergo apoptosis when treated with bortezomib, but the precise molecular mechanism has not been revealed. In addition to this, peripheral neuropathy is the main side effect of chemotherapy that includes bortezomib more

Publications Services

• Energies, Vol. 6, Pages 2521-2540: Activity Sectors and Energy Intensity: Decomposition Analysis and Policy Implications for European Countries (1991–2005)

  This paper studies the change in Energy Intensity (EI) of the main economic activities in the EU15 countries, which represents approximately 45% of their final energy consumption. The purpose is, first, to measure the different patterns between the countries by establishing differentiated typologies more

• Correction

  Correction Nature 497, 7449 (2013). http://www.nature.com/doifinder/10.1038/497301a The News story ‘Targeted drugs to tackle hepatitis C’ (Nature497, 18–19; 2013) wrongly implied that the US Preventive Services Task Force considers financial co more

• EDAM: an ontology of bioinformatics operations, types of data and identifiers, topics and formats

  Motivation: Advancing the search, publication and integration of bioinformatics tools and resources demands consistent machine-understandable descriptions. A comprehensive ontology allowing such descriptions is therefore required. Results: EDAM is an ontology of bioinformatics operations (tool or more

Market studies Services

• Promethean Corporation - Strategic SWOT Analysis Review

  Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also involved in providing various health care services. The company through its wholly owned subsidiary, Ceres Living, produces and sells the AIO Premium more

• Polymer Research Corp. of America - Strategic SWOT Analysis Review

  This comprehensive SWOT profile of Polymer Research Corp. of America provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and t more

• Caleco Pharma Corp. - Strategic SWOT Analysis Review

  Caleco Pharma Corp. (Caleco) is a public company engaged in the development of products to treat moderate to severe liver maladies. The company is developing its proprietary technology for the treatment of moderate to severe liver maladies which include conditions like elevated liver enzymes and the more

Websites Services